Prevalence and significance of isotypes of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis

Annals of the Rheumatic Diseases

Volumn 67, Issue 7, 2008, Pages 1049-1051

  Syed, R H ^a,b   Gilliam, B E ^a   Moore, T L ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Doisy Hall ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ANTIBODY DETECTION; ARTHRITIS; CONTROLLED STUDY; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; JOINT DESTRUCTION; JUVENILE RHEUMATOID ARTHRITIS; LETTER; MAJOR CLINICAL STUDY; MALE; POLYARTHRITIS; PREVALENCE; PRIORITY JOURNAL; PSORIATIC ARTHRITIS;

ADOLESCENT; ARTHRITIS, JUVENILE RHEUMATOID; AUTOANTIBODIES; CHILD; FEMALE; HUMANS; IMMUNOGLOBULIN ISOTYPES; MALE; PEPTIDES, CYCLIC;

EID: 46849116893     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2007.084855     Document Type: Letter

References (8)

1. Gilliam BE, Chauhan AK, Low JM, Moore TL. Measurement of biomarkers in juvenile idiopathic arthritis and their significant association with disease severity: a comparative study. Arthritis Rheum 2007;56:S376.
2. Kasapçopur Ö, Altun S, Asian M, Karaarslan S, Kamburoglu-Goksel A, Saribas, S, et al. Diagnostic accuracy of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. Ann Rheum Dis 2004;63:1687-9.
3. Ferucci ED, Miajka DS, Parrish LA, Moroldo MB, Ryan M, Passo M, et al. Antibodies against cyclic citrullinated peptide are associated with HLA-DR4 in simplex and multiplex polyarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum 2005;52:239-46.
4. Dewint P, Hoffman IEA, Rogge S, Joos R, Union A, Dehoorne J, et al. Effect of age on prevalence of anticitrullinated protein/peptide antibodies in polyarticular juvenile idiopathic arthritis. Rheumatology (Oxford) 2006;45:204-8.
5. van Rossum M, van Soesbergen R, De Kort S, ten Cate R, Zwinderman AH, de Jong B, et al. Anti-cyclic citrullinated peptide (anti-CCP) antibodies in children with juvenile idiopathic arthritis. J Rheumatol 2003;30:825-8.
6. Hromadnikova I, Stechova K, Pavla V, Hridelova D, Houbova B, Voslarova S. Anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis. Autoimmunity 2002;35:397-401.
7. Verpoort KN, Jol-van der Zijde CM, Papendrecht-van der Voort AM, loan-Facsinay A, Drijfhout JW, van Tol MJD, et al. Isotype distribution of anti-cyclic citrullinated peptide antibodies in undifferentiated arthritis and rheumatoid arthritis reflects an ongoing immune response. Arthritis Rheum 2006;54:3799-808.
8. Anzilotti C, Riente L, Pratesi F, Chimenti D, Delle Sedie A, Bombardiert S, et al. IgG, IgA, IgM antibodies to a viral citrullinated peptide in patients affected by rheumatoid arthritis, chronic arthritides and connective tissue disorders. Rheumatology 2007;46:1579-82.